Your monthly support provides voters the knowledge they need to make confident decisions at the polls. Donate today.
Johnson & Johnson
This article is outside of Ballotpedia's coverage scope and does not receive scheduled updates. If you would like to help our coverage scope grow, consider donating to Ballotpedia.
| Johnson & Johnson | |
 | |
| Basic facts | |
| Location: | New Brunswick, N.J. |
| Top official: | Alex Gorsky, Chairman and CEO |
| Year founded: | 1886 |
| Website: | Official website |
Johnson & Johnson is a global healthcare company that produces pharmaceuticals, medical devices, biologics, and consumer health products. The company produced Neutrogena, Aveeno, Clean & Clear, and other popular consumer health brands. Johnson & Johnson was based in New Brunswick, New Jersey, as of 2019.[1][2][3]
Background
Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey. Under the brothers' leadership, the company produced a series of medical innovations toward the end of the 19th century, including commercial first aid kits, maternity kits, feminine hygiene products, dental floss, and baby powder. James Wood Johnson assumed leadership of Johnson & Johnson in 1910 and guided the company's expansion into the United Kingdom, Mexico, South Africa, and Australia. Robert Wood Johnson became the head of the company in 1932 and continued to direct the organization's global expansion into Brazil and Argentina.[5]
Johnson & Johnson became a publicly-traded company in 1944. The organization acquired the pharmaceutical companies McNeil Laboratories and Cilag Chemie, AG, in 1959 and began to produce medicines, such as Tylenol, in addition to consumer health products. During the second half of the 20th century, Johnson & Johnson increased its line of personal care products, developed new medical treatments for schizophrenia and diabetes, entered the vision care market, and continued its global expansion into China, Egypt, Russia, and Eastern Europe.[5]
During the early 21st century, Johnson & Johnson worked to develop treatments and therapies for HIV/AIDS, tuberculosis, and infectious diseases. As of October 2016, Johnson & Johnson was made up of over 265 subsidiary companies across more than 60 countries.[1][5]
Political activity
Johnson & Johnson aims to support its public policy priorities through participation in U.S. political process. According to the company's website, Johnson & Johnson seeks "to provide leadership in advancing a world in which all people have access to affordable, innovative, and sustainable solutions for healthy living."[6]
Johnson & Johnson makes political contributions to federal candidates through J&JPAC, its voluntary, employee-funded political action committee. The company also makes direct corporate contributions to state candidates, state political party committees, and ballot measure committees when permissible by law. In addition, Johnson & Johnson is a member of 501(c)(6) professional industry and trade organizations that aim to advocate for the interests of the pharmaceutical industry, such as Pharmaceutical Research and Manufacturers of America (PhRMA).[7][8]
Lobbying
The following table displays Johnson & Johnson's federal lobbying expenditures from 2010 through 2015 according to the Center for Responsive Politics:[9]
| Federal lobbying expenditures for Johnson & Johnson, 2010-2015 | ||
|---|---|---|
| Year | Total expenditures | |
| 2015 | $6,350,000 | |
| 2014 | $5,980,000 | |
| 2013 | $5,630,000 | |
| 2012 | $5,880,000 | |
| 2011 | $5,806,000 | |
| 2010 | $6,700,000 | |
Ballot measure activity
Johnson & Johnson was a sponsor of the Californians Against the Deceptive RX Proposition ballot measure committee. The committee opposed the 2016 California Drug Price Standards Initiative (Proposition 61), which proposed to regulate drug prices by requiring state agencies to pay the same prices for prescription drugs as the U.S. Department of Veterans Affairs (VA).[4][10]
Overview of ballot measure support and opposition
The following table details the ballot measure stances for Johnson & Johnson available on Ballotpedia:
| Ballot measure support and opposition for Johnson & Johnson | |||
|---|---|---|---|
| Ballot measure | Year | Position | Status |
| California Proposition 61, Drug Price Standards (2016) | 2016 | Opposed[4] |  Defeated
|
Leadership
The following individuals held leadership positions with Johnson & Johnson as of August 2019:[11]
- Alex Gorsky, Chairman and chief executive officer
- Joaquin Duato, Executive vice president and worldwide chairman, pharmaceuticals
- Peter Fasolo, Executive vice president and chief human resources officer
- Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices
- Thibaut Mongon, Executive Vice President, Worldwide Chairman, Consumer
- Michael Sneed, Worldwide vice president, global corporate affairs
- Paul Stoffels, Executive vice president and chief scientific officer
- Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals
- Michael Ullmann, Executive vice president and general counsel
- Kathryn E. Wengel, Worldwide vice president, Johnson & Johnson supply chain
- Joseph J. Wolk, Executive Vice President, Chief Financial Officer
Recent news
The link below is to the most recent stories in a Google news search for the terms Johnson & Johnson. These results are automatically generated from Google. Ballotpedia does not curate or endorse these articles.
See also
- California Proposition 61, Drug Price Standards (2016)
- California 2016 ballot measures
- Healthcare policy in California
- Robert Wood Johnson Foundation
External links
- Johnson & Johnson homepage
- Johnson & Johnson on Facebook
- Johnson & Johnson on Twitter
- No on Prop 61 homepage
- No on Prop 61 on Twitter
- No on Prop 61 on Facebook
- Pharmaceutical Research and Manufacturers of America homepage
Footnotes
- ↑ 1.0 1.1 Johnson & Johnson, "Our company," accessed October 4, 2016
- ↑ LinkedIn, "Johnson & Johnson," accessed October 4, 2016
- ↑ Johnson & Johnson, "Consumer products," accessed October 27, 2016
- ↑ 4.0 4.1 4.2 California Fair Political Practices Commission, "November 2016 General Election," accessed October 2, 2016, 2016
- ↑ 5.0 5.1 5.2 Johnson & Johnson, "Johnson & Johnson history," accessed October 4, 2016
- ↑ Johnson & Johnson, "Government affairs and programs" accessed October 27, 2016
- ↑ Johnson & Johnson, "Political contributions," accessed October 27, 2016
- ↑ Pharmaceutical Research and Manufacturers of America, "Members," accessed October 26, 2016
- ↑ Center for Responsive Politics, "Johnson & Johnson," accessed October 27, 2016
- ↑ No on Prop 61, "Why the Misleading Rx Measure Will Stifle Scientific Research and Development and Reduce Prescription Drug Access for Patients," accessed October 4, 2016
- ↑ Johnson & Johnson, "Senior management," accessed October 4, 2016
| |||||||
